CHOLESTATIC LIVER DISEASE
Clinical trials for CHOLESTATIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHOLESTATIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for CHOLESTATIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug study aims to understand liver disease treatment
Knowledge-focused Recruiting nowThis early-stage study looks at how the body processes the drug Saroglitazar in people with mild, moderate, or severe liver cirrhosis caused by cholestatic liver disease. About 30 adults aged 18 to 80 will take the drug once daily for 28 days. The goal is to measure drug levels i…
Matched conditions: CHOLESTATIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:15 UTC
-
New drug study aims to understand how liver disease affects medication
Knowledge-focused Recruiting nowThis early-stage study is testing a drug called saroglitazar in 6 adults with moderate liver scarring (cirrhosis) caused by cholestatic liver disease. The main goal is to see how the drug moves through the body and if it is safe when taken every other day. This study does not aim…
Matched conditions: CHOLESTATIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:05 UTC
-
Can DNA testing unlock the mystery of adult liver disease?
Knowledge-focused Recruiting nowThis study aims to find genetic reasons why some adults develop cholestatic liver disease, a condition where bile flow is blocked. Researchers will use whole-genome sequencing to analyze DNA from 60 adults with unexplained or atypical symptoms. The goal is to improve diagnosis an…
Matched conditions: CHOLESTATIC LIVER DISEASE
Phase: NA • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC